TW206966B - - Google Patents

Info

Publication number
TW206966B
TW206966B TW081107195A TW81107195A TW206966B TW 206966 B TW206966 B TW 206966B TW 081107195 A TW081107195 A TW 081107195A TW 81107195 A TW81107195 A TW 81107195A TW 206966 B TW206966 B TW 206966B
Authority
TW
Taiwan
Application number
TW081107195A
Inventor
Muller-Gliemann Matthias
Beuck Martin
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW206966B publication Critical patent/TW206966B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
TW081107195A 1991-10-01 1992-09-14 TW206966B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4132633A DE4132633A1 (de) 1991-10-01 1991-10-01 Cyclisch substituierte imidazolyl-propensaeurederivate

Publications (1)

Publication Number Publication Date
TW206966B true TW206966B (zh) 1993-06-01

Family

ID=6441875

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081107195A TW206966B (zh) 1991-10-01 1992-09-14

Country Status (14)

Country Link
US (1) US5225428A (zh)
EP (1) EP0535465A1 (zh)
JP (1) JPH05213937A (zh)
KR (1) KR930007938A (zh)
AU (1) AU646762B2 (zh)
CA (1) CA2079266A1 (zh)
CZ (1) CZ297792A3 (zh)
DE (1) DE4132633A1 (zh)
HU (1) HUT62578A (zh)
IL (1) IL103292A0 (zh)
MX (1) MX9205434A (zh)
NO (1) NO923581L (zh)
TW (1) TW206966B (zh)
ZA (1) ZA927499B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
CA2186606A1 (en) * 1994-03-29 1995-10-05 Edward B. Nelson Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
US6465502B1 (en) 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
UA90131C2 (en) * 2005-02-03 2010-04-12 Рациофарм Гмбх Method for the production of losartan
EP1741711A1 (en) * 2005-07-04 2007-01-10 KRKA, D.D., Novo Mesto A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1H-imidazole-5-carbaldehydes
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CN107325052B (zh) * 2017-06-19 2020-01-10 广东药科大学 一类具有抗癌活性的咪唑酯类化合物及其衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
ATE190051T1 (de) * 1989-06-14 2000-03-15 Smithkline Beecham Corp Imidazoalkensäure
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
JP2550442B2 (ja) * 1989-06-30 1996-11-06 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 置換イミダゾール
JP2568315B2 (ja) * 1989-06-30 1997-01-08 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 縮合環アリール置換イミダゾール
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
GB9017482D0 (en) * 1990-08-09 1990-09-26 Ici Plc Manufacturing process
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate

Also Published As

Publication number Publication date
ZA927499B (en) 1993-05-03
MX9205434A (es) 1993-04-01
EP0535465A1 (de) 1993-04-07
US5225428A (en) 1993-07-06
AU2602592A (en) 1993-04-08
JPH05213937A (ja) 1993-08-24
IL103292A0 (en) 1993-02-21
DE4132633A1 (de) 1993-04-08
KR930007938A (ko) 1993-05-20
HU9203125D0 (en) 1992-12-28
NO923581L (no) 1993-04-02
AU646762B2 (en) 1994-03-03
HUT62578A (en) 1993-05-28
NO923581D0 (no) 1992-09-15
CZ297792A3 (en) 1993-04-14
CA2079266A1 (en) 1993-04-02

Similar Documents

Publication Publication Date Title
TW206966B (zh)
DE9101095U1 (zh)
DE9100936U1 (zh)
DE9103341U1 (zh)
DE4290290T1 (zh)
DE9104752U1 (zh)
DE9105449U1 (zh)
DE9101162U1 (zh)
DE9104240U1 (zh)
DE9105560U1 (zh)
DE9101021U1 (zh)
DE9104498U1 (zh)
DE9103008U1 (zh)
DE9100412U1 (zh)
DE9105053U1 (zh)
DE9103669U1 (zh)
DE9105466U1 (zh)
DE9100953U1 (zh)
DE9100693U1 (zh)
DE9101605U1 (zh)
DE9100889U1 (zh)
DE9100093U1 (zh)
DE9100895U1 (zh)
DE9104114U1 (zh)
DE9102080U1 (zh)